Peng–Sheng Ting

1.5k total citations · 1 hit paper
28 papers, 936 citations indexed

About

Peng–Sheng Ting is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Peng–Sheng Ting has authored 28 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Hepatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Peng–Sheng Ting's work include Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (7 papers) and Liver Disease and Transplantation (5 papers). Peng–Sheng Ting is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (7 papers) and Liver Disease and Transplantation (5 papers). Peng–Sheng Ting collaborates with scholars based in United States, China and Türkiye. Peng–Sheng Ting's co-authors include Yee Hui Yeo, Brennan Spiegel, Masayuki Yamamoto, James Douglas Engel, Kathleen M. George, Hirsh D. Trivedi, Aarshi Vipani, Alexander Kuo, Omer Liran and Jamil S. Samaan and has published in prestigious journals such as Molecular and Cellular Biology, The American Journal of Gastroenterology and Nutrients.

In The Last Decade

Peng–Sheng Ting

26 papers receiving 919 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

2023 424 citations Yee Hui Yeo, Jamil S. Samaan et al. Clinical and Molecular Hepatology profile →

Peers

Countries citing papers authored by Peng–Sheng Ting

Since Specialization

Citations

This map shows the geographic impact of Peng–Sheng Ting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng–Sheng Ting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng–Sheng Ting more than expected).

Fields of papers citing papers by Peng–Sheng Ting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng–Sheng Ting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng–Sheng Ting. The network helps show where Peng–Sheng Ting may publish in the future.

Co-authorship network of co-authors of Peng–Sheng Ting

This figure shows the co-authorship network connecting the top 25 collaborators of Peng–Sheng Ting. A scholar is included among the top collaborators of Peng–Sheng Ting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng–Sheng Ting. Peng–Sheng Ting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease 2025 ·EMBO Molecular Medicine ·Hongze Chen, Muhammad Azhar Nisar, (unknown), Xinjian Li, (unknown), Shaolei Lu, Katsuya Nagaoka, (unknown), Peng–Sheng Ting, Tung‐Sung Tseng, Hui‐Yi Lin, Xiao-Ming Yin, Wenke Feng, Zhijin Wu, Zhixiang Cheng, William F. Mueller, (unknown), (unknown), Xuewei Bai, Chiung‐Kuei Huang	1
2	Trends in Concurrent Psychiatric Comorbidities in Alcohol-Associated Liver Disease: A Nationwide Study from 2015–2023 2025 ·Digestive Diseases and Sciences ·(unknown), Yee Hui Yeo, Hyun‐Seok Kim, (unknown), (unknown), Pojsakorn Danpanichkul, Peng–Sheng Ting	0
3	Postdischarge Alcohol Cessation and Psychiatric Referrals in Alcoholic Liver Disease 2025 ·JAMA Network Open ·(unknown), Yee Hui Yeo, Hyun‐Seok Kim, (unknown), Yueh‐Ting Tsai, Peng–Sheng Ting	1
4	Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasia in close proximity to esophageal varices: a multicenter international experience 2023 ·Endoscopy ·(unknown), Bing Hu, Abel Joseph, Hiroyuki Aihara, Lorenzo Ferri, Amit Bhatt, Amit Mehta, Peng–Sheng Ting, Alex Chen, Andrew Kalra, Jad Farha, Manabu Onimaru, (unknown), Qi Luo, Andrew Y. Wang, Haruhiro Inoue, Saowanee Ngamruengphong	2
5	ChatGPT’s ability to comprehend and answer cirrhosis related questions in Arabic 2023 ·Arab Journal of Gastroenterology ·Jamil S. Samaan, Yee Hui Yeo, Wee Han Ng, Peng–Sheng Ting, Hirsh D. Trivedi, Aarshi Vipani, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo, Walid S. Ayoub	20
6	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma breakdown → 2023 ·Clinical and Molecular Hepatology ·Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng–Sheng Ting, Hirsh D. Trivedi, Aarshi Vipani, Walid S. Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo	424
7	Exclusive liquor and cocktail consumption is associated with at‐risk fibrosis among nonheavy alcohol users with metabolic dysfunction‐associated steatotic liver disease 2023 ·Alcohol Clinical and Experimental Research ·Peng–Sheng Ting, Wei‐Ting Lin, Chiung‐Kuei Huang, Hui‐Yi Lin, Tung‐Sung Tseng, Po‐Hung Chen	4
8	Sugar-Sweetened Beverages and Artificially Sweetened Beverages Consumption and the Risk of Nonalcoholic Fatty Liver (NAFLD) and Nonalcoholic Steatohepatitis (NASH) 2023 ·Nutrients ·Tung‐Sung Tseng, Wei‐Ting Lin, Peng–Sheng Ting, Chiung‐Kuei Huang, Po‐Hung Chen, (unknown), Hui‐Yi Lin	15
9	Exertional Heat Stroke-Induced Acute Liver Failure and Liver Transplantation 2022 ·ACG Case Reports Journal ·Jessica Lin, (unknown), (unknown), Peng–Sheng Ting, Tinsay A. Woreta, Amy Kim, (unknown), Kiyoko Oshima, Andrew M. Cameron, Benjamin Philosophe, Shane Ottmann, Russell Wesson, Ahmet Gürakar	3
10	Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States 2022 ·Experimental and Clinical Transplantation ·(unknown), Merve Gürakar, Peng–Sheng Ting, (unknown), (unknown), (unknown), Saleh A. Alqahtani, Alan Bonder, Ahmet Gürakar, Behnam Saberi	4
11	S2956 Delayed Onset Drug-Induced Acute Liver Failure Caused by Glatiramer Acetate (GA) in Multiple Sclerosis Requiring Liver Transplantation 2022 ·The American Journal of Gastroenterology ·(unknown), Chung‐Wei Christine Lin, (unknown), Kiyoko Oshima, (unknown), Russell Wesson, Peng–Sheng Ting, Shane Ottmann, Ahmet Gürakar	0
12	Hepatitis D virus and liver transplantation: Indications and outcomes 2021 ·World Journal of Hepatology ·(unknown), (unknown), (unknown), Peng–Sheng Ting, (unknown), Ahmet Gürakar	16
13	Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review 2021 ·Journal of Clinical and Translational Hepatology ·(unknown), (unknown), Peng–Sheng Ting, Merve Gürakar, Sean Li, Cem Şimşek, Saleh A. Alqahtani, Amy K. Kim, (unknown), Ahmet Gürakar	17
14	Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis 2021 ·Clinics in Liver Disease ·Peng–Sheng Ting, Ahmet Gürakar, (unknown), Geetanjali Chander, Andrew M. Cameron, Po‐Hung Chen	7
15	Inter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic 2021 ·Alcohol and Alcoholism ·Po‐Hung Chen, Peng–Sheng Ting, (unknown), Geetanjali Chander, Andrew M. Cameron, Ahmet Gürakar	19
16	Behavioral Treatment for Patients With Alcohol‐Related Liver Disease: A Primer for Hepatologists 2020 ·Clinical Liver Disease ·Peng–Sheng Ting, (unknown), Po‐Hung Chen	6
17	A Mimic of Hepatic Encephalopathy: Two Cases of Cryptococcal Meningitis in North America 2019 ·Journal of Clinical and Translational Hepatology ·Peng–Sheng Ting, (unknown), Tinsay A. Woreta	2
18	Gender and age disparity in the initiation of life-supporting treatments: a population-based cohort study 2017 ·BMC Medical Ethics ·Peng–Sheng Ting, Likwang Chen, (unknown), Tien‐Shang Huang, Chau‐Chung Wu, Yen‐Yuan Chen	8
19	Microarray analysis of differentially expressed genes in preeclamptic and normal placental tissues 2014 ·Clinical and Experimental Obstetrics & Gynecology ·(unknown), (unknown), Shufeng Zhou, Rong Hu, Yu Xiong, Peng–Sheng Ting, Xiaotian Li, (unknown)	1
20	Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. 1991 ·Molecular and Cellular Biology ·(unknown), Masayuki Yamamoto, (unknown), Kathleen M. George, Peng–Sheng Ting, James Douglas Engel	266

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact